Literature DB >> 6517560

Improved micromethod for mezlocillin quantitation in serum and urine by high-pressure liquid chromatography.

D Fiore, F A Auger, G L Drusano, V R Dandu, L J Lesko.   

Abstract

A rapid, sensitive, and specific method of analysis for mezlocillin in serum and urine by high-pressure liquid chromatography is described. A solid-phase extraction column was used to remove interfering substances from samples before chromatography. Quantitation included the use of an internal standard, nafcillin. Mezlocillin was chromatographed with a phosphate buffer-acetonitrile (73:27) mobile phase and a C-18 reverse-phase column and detected at a wavelength of 220 nm. The assay had a sensitivity of 1.6 micrograms/ml and a linearity of up to 600 micrograms/ml and 16 mg/ml in serum and urine, respectively, with only 0.1 ml of sample. The interday and intraday coefficients of variation for replicate analyses of spiked serum and urine specimens were less than 6.5%.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6517560      PMCID: PMC180013          DOI: 10.1128/AAC.26.5.775

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  8 in total

1.  High-pressure liquid chromatographic quantitation of azlocillin.

Authors:  A Weber; K E Opheim; K Wong; A L Smith
Journal:  Antimicrob Agents Chemother       Date:  1983-11       Impact factor: 5.191

2.  Nonlinear mezlocillin kinetics due to dose-dependent metabolism.

Authors:  U Gundert-Remy; R Hildebrandt; A Stiehl; E Weber
Journal:  Clin Pharmacol Ther       Date:  1983-05       Impact factor: 6.875

3.  Improved procedure for the determination of the ureidopenicillins azlocillin and mezlocillin plasma by high-performance liquid chromatography.

Authors:  R Hildebrandt; U Gundert-Remy
Journal:  J Chromatogr       Date:  1982-03-12

4.  Effects of impaired renal function, hemodialysis, and peritoneal dialysis on the pharmacokinetics of mezlocillin.

Authors:  D Kampf; R Schurig; K Weihermüller; D Förster
Journal:  Antimicrob Agents Chemother       Date:  1980-07       Impact factor: 5.191

5.  Mezlocillin pharmacokinetics in pediatric oncology patients.

Authors:  W G Kramer; L K Pickering; S Culbert; L S Frankel
Journal:  Antimicrob Agents Chemother       Date:  1984-01       Impact factor: 5.191

6.  Determination of the ureidopenicillins azlocillin, mezlocillin and bay K 4999 in plasma by high performance liquid chromatography.

Authors:  U Gundert-Remy; J X De Vries
Journal:  Br J Clin Pharmacol       Date:  1979-12       Impact factor: 4.335

Review 7.  The acylampicillins: mezlocillin, piperacillin, and azlocillin.

Authors:  G L Drusano; S C Schimpff; W L Hewitt
Journal:  Rev Infect Dis       Date:  1984 Jan-Feb

8.  Mezlocillin pharmacokinetics in patients with normal and impaired renal functions.

Authors:  T Bergan; E K Brodwall; E Wiik-Larsen
Journal:  Antimicrob Agents Chemother       Date:  1979-11       Impact factor: 5.191

  8 in total
  2 in total

1.  Determination of mezlocillin and its penicilloate and penilloate by high-performance liquid chromatography and stability of mezlocillin at different temperatures.

Authors:  J Knöller; K D Bremm; W Schönfeld; W König
Journal:  Antimicrob Agents Chemother       Date:  1986-03       Impact factor: 5.191

2.  The penetration of antibiotics into human pancreas.

Authors:  M Büchler; P Malfertheiner; H Friess; R Bittner; E Vanek; P Schlegel; H G Beger
Journal:  Infection       Date:  1989 Jan-Feb       Impact factor: 3.553

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.